Regulatory T cells in peripheral blood of patients with mixed connective tissue disease

被引:20
作者
Barath, S.
Sipka, S.
Aleksza, M.
Szegedi, A.
Szodoray, P.
Vegh, J.
Szegedi, G.
Bodolay, E.
机构
[1] Univ Debrecen, Dept Internal Med 3, Med & Hlth Sci Ctr, H-4004 Debrecen, Hungary
[2] Univ Debrecen, Dept Dermatol, Med & Hlth Sci Ctr, H-4004 Debrecen, Hungary
关键词
D O I
10.1080/03009740600709790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the percentage and absolute number of CD4(+) regulatory T-cells ( Treg) in 48 patients with mixed connective tissue disease ( MCTD). Methods: Data were classified on the basis of the stage of the disease: 17 patients were in the active stage and 31 in the inactive stage. The absolute number of CD4(+)/ intracellular interleukin- 10(+) (IL-10(+)) and CD4(+) CD25(+) high Treg cells was determined by flow cytometry. The percentage of CD4+ CD25+ high suppressor T- cells was determined on the basis of Foxp3 expression. Results: The percentage and the absolute number of CD4+ CD25+ high Treg cells were lower in patients than in healthy controls (p < 0.04), and were further decreased in patients with active MCTD and were lower than in the inactive stage (p < 0.01). There was an increase in the percentage and absolute number of CD4(+) IL-10(+) Treg cells in patients with MCTD compared to the healthy controls ( pv0.02). The percentage of CD4+ IL- 10+ Treg cells was higher in the active stage of MCTD than in the inactive stage of the disease (p < 0.005). However, we did not find any significant difference in the absolute number of CD4(+) IL-10(+) Treg cells between the patients in the active and inactive stages of MCTD. Conclusion: Our results suggest that the decrease in the number of CD4(+) CD25(+) high Treg cells in an important factor in the immunoregulatory disturbance in patients with MCTD. We suggest that the increase in the number of CD4(+) IL-10(+) Treg cells is a compensatory mechanism aiming to restore the balance between type 1 and type 2 cytokines in MCTD.
引用
收藏
页码:300 / 304
页数:5
相关论文
共 24 条
[1]  
Alarcon-Segovia D., 1987, Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, P33
[2]   An elevated level of IL-10- and TGFβ-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis [J].
Appel, H ;
Neure, L ;
Kuhne, M ;
Braun, J ;
Rudwaleit, M ;
Sieper, J .
CLINICAL RHEUMATOLOGY, 2004, 23 (05) :435-440
[3]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[4]   Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD) [J].
Bodolay, E ;
Szekanecz, Z ;
Dévényi, K ;
Galuska, L ;
Csípo, I ;
Vègh, J ;
Garai, I ;
Szegedi, G .
RHEUMATOLOGY, 2005, 44 (05) :656-661
[5]  
Bodolay E, 2002, J RHEUMATOL, V29, P2136
[6]   IL-10-producing T cells suppress immune responses in anergic tuberculosis patients [J].
Boussiotis, VA ;
Tsai, EY ;
Yunis, EJ ;
Thim, S ;
Delgado, JC ;
Dascher, CC ;
Berezovskaya, A ;
Rousset, D ;
Reynes, JM ;
Goldfeld, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1317-1324
[7]   The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo [J].
Doganci, A ;
Eigenbrod, T ;
Krug, N ;
De Sanctis, GT ;
Hausding, M ;
Erpenbeck, VJ ;
Haddad, EB ;
Schmitt, E ;
Bopp, T ;
Kallen, KJ ;
Herz, U ;
Schmitt, S ;
Luft, C ;
Hecht, O ;
Hohlfeld, JM ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Kishimoto, T ;
Rose-John, S ;
Renz, H ;
Neurath, MF ;
Galle, PR ;
Finotto, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :313-325
[8]   Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis:: effect of immunosuppressive treatment [J].
Fattorossi, A ;
Battaglia, A ;
Buzzonetti, A ;
Ciaraffa, F ;
Scambia, G ;
Evoli, A .
IMMUNOLOGY, 2005, 116 (01) :134-141
[9]  
Greidinger EL, 2001, ARTHRITIS RHEUM, V44, P368
[10]  
Hassan AB, 2001, SCAND J RHEUMATOL, V30, P282